Logo image of PTN

PALATIN TECHNOLOGIES INC (PTN) Stock Fundamental Analysis

NYSEARCA:PTN - American Stock Exchange - US6960775020 - Common Stock

1.1  +0.04 (+3.77%)

After market: 1.12 +0.02 (+1.82%)

Fundamental Rating

2

Taking everything into account, PTN scores 2 out of 10 in our fundamental rating. PTN was compared to 572 industry peers in the Biotechnology industry. PTN has a bad profitability rating. Also its financial health evaluation is rather negative. PTN has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year PTN has reported negative net income.
In the past year PTN has reported a negative cash flow from operations.
PTN had negative earnings in each of the past 5 years.
In the past 5 years PTN reported 4 times negative operating cash flow.
PTN Yearly Net Income VS EBIT VS OCF VS FCFPTN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

1.2 Ratios

With a Return On Assets value of -947.33%, PTN is not doing good in the industry: 98.94% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -947.33%
ROE N/A
ROIC N/A
ROA(3y)-176.98%
ROA(5y)-121.45%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PTN Yearly ROA, ROE, ROICPTN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10K -10K 20K -20K

1.3 Margins

Looking at the Gross Margin, with a value of 184.24%, PTN belongs to the top of the industry, outperforming 99.29% of the companies in the same industry.
PTN's Gross Margin has declined in the last couple of years.
PTN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 184.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-18.23%
GM growth 5YN/A
PTN Yearly Profit, Operating, Gross MarginsPTN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10K -10K

More info and screens

0

2. Health

2.1 Basic Checks

PTN does not have a ROIC to compare to the WACC, probably because it is not profitable.
PTN has more shares outstanding than it did 1 year ago.
PTN has more shares outstanding than it did 5 years ago.
PTN has a better debt/assets ratio than last year.
PTN Yearly Shares OutstandingPTN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
PTN Yearly Total Debt VS Total AssetsPTN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of -215.84, we must say that PTN is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -215.84, PTN is not doing good in the industry: 98.76% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -215.84
ROIC/WACCN/A
WACC11.14%
PTN Yearly LT Debt VS Equity VS FCFPTN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

A Current Ratio of 0.26 indicates that PTN may have some problems paying its short term obligations.
The Current ratio of PTN (0.26) is worse than 96.28% of its industry peers.
A Quick Ratio of 0.26 indicates that PTN may have some problems paying its short term obligations.
With a Quick ratio value of 0.26, PTN is not doing good in the industry: 95.75% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.26
Quick Ratio 0.26
PTN Yearly Current Assets VS Current LiabilitesPTN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

4

3. Growth

3.1 Past

PTN shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.91%.
The Revenue for PTN has decreased by -60.92% in the past year. This is quite bad
The Revenue for PTN have been decreasing by -40.52% on average. This is quite bad
EPS 1Y (TTM)7.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.75%
Revenue 1Y (TTM)-60.92%
Revenue growth 3YN/A
Revenue growth 5Y-40.52%
Sales Q2Q%-100%

3.2 Future

PTN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 30.24% yearly.
The Revenue is expected to grow by 162.67% on average over the next years. This is a very strong growth
EPS Next Y0.95%
EPS Next 2Y52.7%
EPS Next 3Y48.26%
EPS Next 5Y30.24%
Revenue Next Year-100%
Revenue Next 2Y325.2%
Revenue Next 3Y164.44%
Revenue Next 5Y162.67%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PTN Yearly Revenue VS EstimatesPTN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 100M 200M 300M 400M 500M
PTN Yearly EPS VS EstimatesPTN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 -4 -6

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

PTN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 1.60 indicates a rather cheap valuation of PTN.
99.65% of the companies in the same industry are more expensive than PTN, based on the Price/Forward Earnings ratio.
PTN is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.44, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 1.6
PTN Price Earnings VS Forward Price EarningsPTN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PTN Per share dataPTN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1 -1.5

4.3 Compensation for Growth

PTN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PTN's earnings are expected to grow with 48.26% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y52.7%
EPS Next 3Y48.26%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for PTN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PALATIN TECHNOLOGIES INC

NYSEARCA:PTN (1/21/2025, 8:22:13 PM)

After market: 1.12 +0.02 (+1.82%)

1.1

+0.04 (+3.77%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-14 2024-11-14/bmo
Earnings (Next)02-13 2025-02-13/bmo
Inst Owners14.88%
Inst Owner Change3.2%
Ins Owners0.96%
Ins Owner Change-3.01%
Market Cap21.50M
Analysts80
Price Target17.34 (1476.36%)
Short Float %5.02%
Short Ratio2.19
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.54%
Min EPS beat(2)10.8%
Max EPS beat(2)24.29%
EPS beat(4)2
Avg EPS beat(4)-35.81%
Min EPS beat(4)-172.69%
Max EPS beat(4)24.29%
EPS beat(8)3
Avg EPS beat(8)-24.81%
EPS beat(12)5
Avg EPS beat(12)-21.17%
EPS beat(16)7
Avg EPS beat(16)-25%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)47.83%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-61.54%
EPS NY rev (1m)0%
EPS NY rev (3m)-72.03%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)-100%
Revenue NY rev (1m)N/A
Revenue NY rev (3m)-100%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 1.6
P/S 9.02
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.98
EYN/A
EPS(NY)0.69
Fwd EY62.44%
FCF(TTM)-1.67
FCFYN/A
OCF(TTM)-1.67
OCFYN/A
SpS0.12
BVpS-0.39
TBVpS-0.39
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -947.33%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 184.24%
FCFM N/A
ROA(3y)-176.98%
ROA(5y)-121.45%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-18.23%
GM growth 5YN/A
F-Score3
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.26
Quick Ratio 0.26
Altman-Z -215.84
F-Score3
WACC11.14%
ROIC/WACCN/A
Cap/Depr(3y)120.27%
Cap/Depr(5y)96.16%
Cap/Sales(3y)9.17%
Cap/Sales(5y)16.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.75%
EPS Next Y0.95%
EPS Next 2Y52.7%
EPS Next 3Y48.26%
EPS Next 5Y30.24%
Revenue 1Y (TTM)-60.92%
Revenue growth 3YN/A
Revenue growth 5Y-40.52%
Sales Q2Q%-100%
Revenue Next Year-100%
Revenue Next 2Y325.2%
Revenue Next 3Y164.44%
Revenue Next 5Y162.67%
EBIT growth 1Y-3.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-16.48%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-0.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1.52%
OCF growth 3YN/A
OCF growth 5YN/A